JIR
EGRX

James Investment Research’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

James Investment Research’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,704
Closed -$48K – 558
2023
Q1 		$48K Buy
+1,704
New +$48K 0.01% 368
2017
Q3 		– Sell
-14,470
Closed -$1.14M – 815
2017
Q2 		$1.14M Buy
+14,470
New +$1.14M 0.04% 390